Regression of Kaposi's sarcoma after intravenous immunoglobulin treatment for polymyositis

Yehuda Carmeli*, Dror Mevorach, Naftali Kaminski, Eyal Raz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Abstract

The authors report on the case of a patient with polymy‐ositis who was given immunosuppressive therapy and then developed Kaposi's sarcoma. Subsequently, the polymyositis was treated with high dose intravenous immunoglobulin, and the Kaposi's sarcoma regressed abruptly. The association between these two diseases and the beneficial effect of intravenous immunoglobulin on Kaposi's sarcoma are discussed. Cancer 1994; 73:2859–61.

Original languageEnglish
Pages (from-to)2859-2861
Number of pages3
JournalCancer
Volume73
Issue number11
DOIs
StatePublished - 1 Jun 1994
Externally publishedYes

Fingerprint

Dive into the research topics of 'Regression of Kaposi's sarcoma after intravenous immunoglobulin treatment for polymyositis'. Together they form a unique fingerprint.

Cite this